Mapi Research Trust Announces New Distribution Partnership with Inflexxion, an IBH Company
Mapi Research Trust (MRT) is excited to announce a new partnership with Inflexxion, an Integrated Behavioral Health (IBH) Company, for the distribution of their clinical outcome assessments. Inflexxion and IBH provide innovative technology-based tools and effective treatments for employee assistance, workers compensation programs, substance abuse and opioid addiction, behavioral health, and wellness management. MRT will manage the licensing, distribution, and coordination and development of translations for Inflexxion’s scales, which include the following:
- ASAT – Addiction Severity Assessment Tool
- COMM – Current Opioid Misuse Measure
- ISE – Infertility Self-Efficacy Scale
- OSES – Opioid Side Effects Scale
- PoRI – Post-Operative Recovery Index
- SOAPP-R – Screener and Opioid Assessment for Patients with Pain – Revised
- SOAPP-12 – Screener and Opioid Assessment for Patients with Pain – 12-item version
Additionally, MRT will manage the licensing for Inflexxion’s online PainCAS tool. PainCAS is the only clinical tool of its kind to continually assess benefits and risks associated with opioid therapy throughout the entire patient journey. It includes online short-form versions of the Current Opioid Misuse Measure (COMM-9), the Screener and Opioid Assessment for Patients with Pain (SOAPP-8) and the Pain and Functioning Index (PFI). PainCAS offers provider reports that present a graphical overview of treatment progress as well as patient reports to keep the patient informed and engaged in treatment.
To access any of these instruments, please submit a request through MRT’s ePROVIDE platform. If you are interested in other clinical assessments such as the ASI-MV, BHI-MV, or CHAT, please reach out directly to Inflexxion.